RSSCategory: Drugs

To save on drug costs, insurer wants to steer you to ‘preferred’ pharmacies.

To save on drug costs, insurer wants to steer you to ‘preferred’ pharmacies.

By Pauline Bartolone Kaiser Health News One of California’s largest insurers has proposed a change in the benefits of commercial plans next year that would require consumers to pay more for drugs at pharmacies outside an established network. Blue Shield of California wants to create “a tiered pharmacy network” in its 2018 small- and large-group plans, […]

March 10, 2017 | By | Reply More
‘Right-to-try’ laws expose dying patients to exploitation, ethicists warn

‘Right-to-try’ laws expose dying patients to exploitation, ethicists warn

By Carrie Feibel, KQED Kaiser Health News In the past three years, 33 U.S. states have passed laws aimed at helping dying people get easier access to experimental treatments. Supporters say these patients are just looking for the “right to try” these treatments. Such laws may sound compassionate, but medical ethicists warn they pose worrisome […]

March 6, 2017 | By | Reply More
Patient advocacy groups rake in donations from pharma

Patient advocacy groups rake in donations from pharma

By Emily Kopp Kaiser Health News High-profile advocacy groups for patients with cancer, Alzheimer’s, HIV and other diseases almost always accept funding from pharmaceutical firms, and many fail to report any contributions, new research shows. At least 83 percent of the nation’s 104 largest patient advocacy groups take contributions from the drug, medical device and […]

March 1, 2017 | By | Reply More
WHO lists top ‘superbug’ threats

WHO lists top ‘superbug’ threats

WHO publishes list of bacteria for which new antibiotics are urgently needed World Health Organization (WHO) published its first ever list of antibiotic-resistant “priority pathogens” – a catalogue of 12 families of bacteria that pose the greatest threat to human health. The list was drawn up in a bid to guide and promote research and […]

February 28, 2017 | By | Reply More
NIH-supported trials of testosterone therapy in older men report mixed results

NIH-supported trials of testosterone therapy in older men report mixed results

From the National Institutes of Health Hormone treatment improved bone strength and hemoglobin levels; may increase cardiovascular risk; had no effect on cognition. In older men with low testosterone, one year of testosterone treatment improved bone density and corrected anemia of both known and unknown causes, but also increased the volume of coronary artery plaque, […]

February 21, 2017 | By | Reply More
Mumps continue to spread in King County

Mumps continue to spread in King County

Mumps continue to spread in King County: Know the symptoms By Hilary N. Karasz Public Health – Seattle & King County There have been 196 cases of mumps reported in King County since the beginning of the outbreak in late November, with the vast majority of cases in the Auburn area. The number of mumps cases across the state has risen […]

February 21, 2017 | By | Reply More
Can marijuana ease the opioid epidemic?

Can marijuana ease the opioid epidemic?

By Christine Vestal Stateline NEW YORK — After a 12-year battle with debilitating abdominal conditions that forced her to stop working, marijuana has helped Lynn Sabulski feel well enough to look for a job. Sabulski is among nearly 14,000 patients in New York state who are certified to use medical marijuana for one of 10 conditions, including […]

February 21, 2017 | By | Reply More
Docs in Northwest tweak aid-in-dying drugs to prevent prolonged deaths

Docs in Northwest tweak aid-in-dying drugs to prevent prolonged deaths

By JoNel Aleccia Kaiser Health News Two years after an abrupt price hike for a lethal drug used by terminally ill patients to end their lives, doctors in the Northwest are once again rethinking aid-in-dying medications — this time because they’re taking too long to work. The concerned physicians say they’ve come up with yet another alternative […]

February 21, 2017 | By | Reply More
5 reasons why an $89,000 drug has Congress fuming

5 reasons why an $89,000 drug has Congress fuming

By Sarah Jane Tribble and Sydney Lupkin Kaiser Health News The latest flashpoint in the ongoing debate over high drug prices is Emflaza, an $89,000-a-year drug that treats Duchenne muscular dystrophy. People who have been watching the drug price issue closely, however, can reasonably ask why there is so much heat at that price tag? […]

February 16, 2017 | By | Reply More
How long patients stay on opioids may depend on the doctor you see in the E.R.

How long patients stay on opioids may depend on the doctor you see in the E.R.

By Jenny Gold Kaiser Health News Which doctor a person happens to see at a local emergency room can have long-term consequences when it comes to opioid use. Within the same hospital, some doctors are three times more likely to prescribe an opioid than other doctors, and patients treated by high-prescribing doctors are more likely […]

February 16, 2017 | By | Reply More